Related Experiment Video
Updated: Dec 31, 2025

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Sleep-disordered breathing in cystic fibrosis pediatric subjects
Magali Santos Lumertz1, Leonardo Araujo Pinto1
1PUCRS, Pediatric Pulmonology - Porto Alegre - RS - Brazil.
Insights
Sleep-disordered breathing (SDB) is common in children with cystic fibrosis (CF). Markers of CF lung disease severity correlate with sleep breathing issues, highlighting the importance of sleep studies.
Area of Science:
- Pediatric Pulmonology
- Sleep Medicine
- Cystic Fibrosis Research
Background:
- Sleep-disordered breathing (SDB) is a potential complication in pediatric cystic fibrosis (CF).
- Assessing SDB and its relationship with CF progression is crucial for patient management.
Purpose of the Study:
- To determine the prevalence of SDB in pediatric CF patients.
- To investigate associations between polysomnographic respiratory parameters and clinical data in CF.
Main Methods:
- Retrospective, cross-sectional study utilizing patient chart data from 2015-2016.
- Included pediatric CF patients (2-20 years) with recent polysomnography records.
- Defined SDB as apnea-hypopnea index >1 event/hour or SpO2 nadir <90%.
Main Results:
- SDB was identified in 62.5% of the 16 included CF patients (mean age 11 years).
- Forced expiratory volume in 1 second (FEV1) correlated with mean sleep SpO2 (r=0.602, p=0.023) and negatively with peak end-tidal CO2 (r=-0.645, p=0.024).
- Pseudomonas aeruginosa colonization was linked to mean non-REM sleep EtCO2 (p=0.024).
Conclusions:
- SDB is frequent in pediatric CF patients.
- Clinical markers of CF respiratory disease are associated with sleep breathing parameters.
- Sleep studies, including CO2 monitoring, are valuable for assessing respiratory status in CF.
Objectives:
To describe the frequency of sleep-disordered breathing (SDB) in pediatric cystic fibrosis (CF) and to study associations between polysomnographic respiratory parameters and available clinical information.
Methods:
This was a retrospective, cross-sectional study. The sample data were obtained from information recorded on patient charts in 2015 and 2016. The study included all individuals with CF aged from 2 to 20 years for whom records were available for polysomnography performed within the previous two years.
Results:
Sixteen individuals with CF (mean age 11 ± 5.6 years old) were included. Polysomnographic respiratory parameter abnormalities were defined as an apnea-hypopnea index (AHI) exceeding one event per hour of sleep or an oxyhemoglobin saturation (SpO2) nadir below 90%; observed in 10 subjects (62.5%). Forced expiratory volume in first second (FEV1) was correlated (r=0.602, p=0.023) with mean sleep SpO2. FEV1 was also negatively correlated with sleep peak end-tidal carbon dioxide (EtpCO2) (r=-0.645, p=0.024). Additionally, chronic airway colonization by Pseudomonas aeruginosa was associated with mean EtpCO2 in non-REM sleep (p=0.024).
Discussion:
SDB was frequently observed in this sample of children with CF. There was an association between CF respiratory disease progression markers and sleep breathing parameters in children. Sleep studies appear to be an important tool for assessment of the respiratory status of these individuals with CF, although further studies are needed, especially with carbon dioxide sleep analysis.
More Related Videos
Related Concept Videos
Physical Assessment of the Respiratory Tract II: Inspection
Chest Configuration
The chest configuration...
Sleep Apnea
The condition is more prevalent among...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Alterations in Respiration II
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes...
Cystic Fibrosis: Management
Sinus disease and chronic...
Respiratory Volumes and Capacities I

